Eton Pharmaceuticals (ETON) Earnings Analysis

Eton Pharmaceuticals (ETON) next reports earnings on 2026-08-06, consensus EPS 0.13 USD. Last quarter (2026-05-14) it missed with EPS 0.05 USD vs 0.1 USD est (-50%). It has beaten estimates in 1/6 recent quarters (17%). Trailing P/E -852.84.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does ETON next report earnings?

Next earnings date2026-08-06
Consensus EPS estimate0.13 USD
Revenue estimate0.03B

ETON earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-140.05 USD0.1 USD-50%Miss
2026-03-190.05 USD0.12 USD-58.3%Miss
2025-11-06-0.07 USD0.16 USD-143.8%Miss
2025-08-07-0.1 USD-0.01 USD-900%Miss
2025-03-18-0.02 USD-0.02 USD0%Beat
2024-08-08-0.12 USD-0.07 USD-71.4%Miss

Beat rate: 1/6 (17%) over reported quarters with consensus data.

ETON valuation and analyst view

Trailing P/E-852.84
Trailing EPS-0.05406 USD
Price / book38.84
Dividend yield0.00%
Market cap1.19B
Analyst consensusBuy (6 buy / 0 hold / 0 sell)
Avg price target58.5 USD

Related research pages

Frequently asked questions

When is Eton Pharmaceuticals (ETON)'s next earnings date?

Eton Pharmaceuticals is next scheduled to report on 2026-08-06, with a consensus EPS estimate of 0.13 USD and revenue estimate of 0.03B.

Did ETON beat earnings last quarter?

In its 2026-05-14 report, ETON posted EPS of 0.05 USD versus a 0.1 USD estimate — a miss of 50%.

What is ETON's earnings track record?

Over the last 6 reported quarters with consensus data, ETON beat estimates 1 times (17%).

What is ETON's current P/E ratio and EPS?

ETON trades at a trailing P/E of -852.84 on trailing EPS of -0.05405900678028221 USD.

What do analysts rate ETON?

Analyst consensus is "Buy" across 6 ratings (0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 58.5 USD.